Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Promisia HealthcareNZSE:PHL 33 EV-to-FCF is 27.67 as of Jul. 21, 2026. GuruFocus rates NZSE:PHL with a GF Score™ of 33/100 and a GF Value™ of NZ$0.42 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 405 Healthcare Providers & Services companies, Promisia Healthcare ranks worse than 67.16% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Promisia Healthcare's Enterprise Value is NZ$161.23 Mil.
Promisia Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$5.83 Mil. Therefore, Promisia Healthcare's EV-to-FCF for today is 27.67.
The historical rank and industry rank for Promisia Healthcare's EV-to-FCF or its related term are showing as below:
NZSE:PHL'
s EV-to-FCF Range Over the Past 10 Years
Min: -40.4 Med: -3.32 Max: 49.65
Current: 27.49
During the past 13 years, the highest EV-to-FCF of Promisia Healthcare was 49.65. The lowest was -40.40. And the median was -3.32.
NZSE:PHL's EV-to-FCF is ranked worse than 67.16% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 18.06
vs NZSE:PHL: 27.49
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Promisia Healthcare's PE Ratio (TTM) for today is calculated as:
Promisia Healthcare's share price for today is NZ$0.59.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Promisia Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$0.244.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Promisia Healthcare EV-to-FCF Related Terms
Promisia Healthcare EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Promisia Healthcare's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Promisia Healthcare's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Promisia Healthcare EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Promisia Healthcare's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Promisia Healthcare's EV-to-FCF falls into.
Promisia Healthcare's current Enterprise Value is NZ$161.23 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Promisia Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$5.83 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Promisia Healthcare (NZSE:PHL) has a EV-to-FCF of 27.67 as of Jul. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Promisia Healthcare and its competitors. According to the industry distribution chart, Promisia Healthcare ranks #272 out of 405 companies in the Healthcare Providers & Services industry, placing it in the top 67.2%.
Is Promisia Healthcare's EV-to-FCF too high?
Promisia Healthcare's current EV-to-FCF is 27.67. The Healthcare Providers & Services industry median EV-to-FCF is 18.06. Promisia Healthcare's value of 27.67 is 53.2% above this industry median. Based on the distribution chart, Promisia Healthcare ranks #272 out of 405 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Promisia Healthcare has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Promisia Healthcare's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Promisia Healthcare ranks #272 out of 405 companies for EV-to-FCF. This places Promisia Healthcare in the lower half of its industry. The industry median EV-to-FCF is 18.06. Promisia Healthcare's value of 27.67 is 53.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.06, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Promisia Healthcare's current EV-to-FCF of 27.67 is 53.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Promisia Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Promisia Healthcare's current EV-to-FCF is 27.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promisia Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Promisia Healthcare (NZSE:PHL) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$0.42, compared to a current price of NZ$0.59 — trading 40.5% above its estimated fair value. The current EV-to-FCF is 27.67 and 53.2% above the Healthcare Providers & Services industry median of 18.06. Promisia Healthcare's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Promisia Healthcare (NZSE:PHL), the current EV-to-FCF is 27.67 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Promisia Healthcare (NZSE:PHL) Overvalued in 2026?
Based on GuruFocus' analysis, Promisia Healthcare stock appears to be overvalued.
The current stock price of NZ$0.59 is trading 40.5% above its estimated GF Value™ of NZ$0.42.
GuruFocus considers Promisia Healthcare to be Significantly Overvalued.
Key valuation signals for NZSE:PHL:
EV-to-FCF: 27.67
GF Value™: NZ$0.42 vs. price of NZ$0.59 (40.5% above fair value)
Industry Position: 53.2% above the Healthcare Providers & Services median (#272 of 405)
No single metric tells the full story. See the NZSE:PHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Promisia Healthcare Ltd is engaged in the provision of aged care in New Zealand. The company's services include Resthome Care, Hospital (Continuing) Care, Respite (Short Term) Care, Young Disabled Care, Dementia Care, and others. The Group operates in one operating segment: the provision of aged care in New Zealand.
33GF Score
Get the complete analysis for NZSE:PHL
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:PHL has been successfully added to your 
